Accès ouvert
2026
article
OpenAlex
Amelia Bhatnagar, Harley Harris, Emily Jacobs, Porscha Bumpus-White et autres
Metallo-beta-lactamase (MBL)-producing Enterobacterales are a global public health concern. Infections caused by these pathogens are often hard to treat, with few effective agents currently available. While aztreonam-avibactam only recently gained U.S. and European regulatory approval, laboratories have implemented laboratory-developed tests (LDTs) using …
Ouganda, us, ca
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Giulia Orazi, Alyssa G. Kent, Nadine Wilmott, Desbelet Berhe et autres
Abstract Through their ability to hydrolyze carbapenems, Ambler class D beta-lactamases endanger patients by limiting the clinical efficacy of beta-lactam antimicrobials. Further, plasmid-mediated transmission can increase mobility of carbapenemase genes between bacteria and facilitate their spread between patients. In the United States …
us, pr
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sarah Sabour, Kristin R V Harrington, Ellen O. Martinson, Amelia Bhatnagar et autres
ABSTRACT Carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) are significant public health threats, particularly when harboring carbapenemases. Literature describing the frequencies and phenotypic and genotypic characteristics of isolates harboring multiple carbapenemase genes is limited. Using data collected from the Antimicrobial Resistance …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sara J. Blosser, Amelia Bhatnagar, Susan Bollinger, Samantha R Giffen
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sarah Sabour, Katie Bantle, Amelia Bhatnagar, J. Huang et autres
) carbapenemase genes. During 2017‒2020, 6,026 CRAB isolates from 45 states were tested for targeted carbapenemase genes; 1% (64 of 5,481) of CRAB tested for targeted class A and class B genes were positive, but 83% (3,351 of 4,041) of CRAB tested …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Amelia Bhatnagar, Porscha Bumpus-White, Sarah Sabour, Janine Bodnar et autres
Abstract Background Metallo-β-lactamase-producing Enterobacterales (MBL-E) are a major public health concern as they cause infections with few effective treatment options. Aztreonam-avibactam (AZA) is a β-lactam/β-lactamase inhibitor combination agent in the drug development pipeline that is active against MBL-E. Though clinical studies are …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Amelia Bhatnagar, María-José Machado, Logan Patterson, Karen Anderson et autres
ABSTRACT In 2017, the Centers for Disease Control and Prevention (CDC) established the Antimicrobial Resistance Laboratory Network to improve domestic detection of multidrug-resistant organisms. CDC and four laboratories evaluated a commercial broth microdilution panel. Antimicrobial susceptibility testing using the Sensititre GN7F (ThermoFisher …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Ian Kracalik, D. Cal Ham, Gillian McAllister, Amanda R. Smith et autres
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) producing the Verona integron‒encoded metallo-β-lactamase (VIM) are highly antimicrobial drug-resistant pathogens that are uncommon in the United States. We investigated the source of VIM-CRPA among US medical tourists who underwent bariatric surgery in Tijuana, Mexico. Cases were defined …
us, mx
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Alicia Shugart, Garrett Mahon, J. Huang, Maria Karlsson et autres
Abstract Background Historically, United States’ carbapenem-resistant Enterobacterales (CRE) surveillance and mechanism testing focused on three genera: Escherichia, Klebsiella, and Enterobacter (EsKE); however, other genera can harbour mobile carbapenemases associated with CRE spread. Objectives From January through May 2018, we conducted a 10 …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Amelia Bhatnagar, Sandra Boyd, Sarah Sabour, Janine Bodnar et autres
Aztreonam-avibactam is a drug combination pending phase 3 clinical trials and is suggested for treatment of severe infections caused by metallo-beta-lactamase (MBL)-producing Enterobacterales by combining ceftazidime-avibactam and aztreonam. Beginning in 2019, four Antibiotic Resistance Laboratory Network regional laboratories offered aztreonam-avibactam susceptibility testing …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Susannah L. McKay, Farrell A. Tobolowsky, Erin D. Moritz, Kelly M Hatfield et autres
BACKGROUND: To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. However, performance data are lacking, especially in asymptomatic people. OBJECTIVE: To evaluate the performance of SARS-CoV-2 antigen testing when used for …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Paige Gable, J. Huang, Sarah Gilbert, Susan Bollinger et autres
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing remains essential for early identification and clinical management of cases. We compared the diagnostic performance of 3 specimen types for characterizing SARS-CoV-2 in infected nursing home residents. METHODS: A convenience sample of 17 …
us
(code pays fourni par la source)